Glenmark Pharma, an India-based drug manufacturer that has been the focal point of a spate of recalls in recent years, has issued another. This time, the product pull covers about 1.48 million ...

The revenue from operations at Glenmark Pharma during Q3FY25 also marked a 35.1 per cent year-on-year (YoY) rise to Rs 3,387.6 crore, coming in higher-than-estimates of Rs 3,350 crore. Glenmark Europe ...

Stock Market Today: Glenmark Pharmaceuticals share price gained more than 5% during intraday trades on Monday post Q3 Results that were declared after the market Hours. Glenmark Pharmaceuticals on ...

Feb 14 (Reuters) - India's Glenmark Pharmaceuticals (GLEN.NS), opens new tab reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

Glenmark Pharma has refuted all claims in several lawsuits against the firm and its foreign subsidiary, Glenmark Pharma Inc., USA. The lawsuits were antitrust and consumer protection claims ...

Glenmark Pharmaceuticals on Friday said its consolidated profit after tax stood at Rs 348 crore for the third quarter ended December 31, 2024, aided by strong performance across regions.

Shares of Glenmark Pharmaceuticals Ltd rose 4% on February 17 after the firm gave a strong guidance for FY26 and it returned to black in the December quarter. The drugmaker reported a consolidated ...

Shares of Glenmark Pharma are higher by over 3.50 percent on February 24 following the pharma company settled anti-trust and consumer protection lawsuits against its US subsidiary. Glenmark Pharma ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of latanoprost ophthalmic solution, 0.005% (0.05 mg/mL). Glenmark’s latanoprost ophthalmic solution, 0.005% (0.05 mg/mL) is ...

(RTTNews) - Glenmark Pharmaceuticals Ltd. (GLENMARK.NS), Friday announced that it has introduced Latanoprost Ophthalmic Solution, 0.005 percent, a bioequivalent and therapeutically equivalent ...